Bioxytran Interview at the Emerging Growth Conference

BOSTON, MASSACHUSETTS, April 03, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral causing diseases announced that Bioxtran CCO Michael Sheikh will be discussing the latest peer reviewed journal article and snippet of Bioxtyran’s Long Covid presentation on the Emerging Growth Conference on April 5, 2023 at 10:50am EST. Investors are encouraged to preregister to ensure you are able to attend the conference and receive any updates that are released. Please submit your questions in advance to Questions@EmergingGrowth.com. The Emerging Growth conference is…